A correlation has been shown between poor outcomes in breast cancer and the expression of sodium channels such as ENaC, NaV1.5, VGSC, etc. More studies are needed to ascertain the potential application of these molecular targets as biomarkers in cancer treatment [85,86,87]. This evidence concerns the gene SCN5A and breast carcinoma.